Tesamorelin is a synthetic 44-amino acid GHRH analog studied for growth hormone secretion and lipodystrophy research. ≥99% HPLC-verified. For research use only.
44-amino acid GHRH analog with trans-3-hexenoic acid modification
Every lot independently verified by third-party laboratories
Full Certificate of Analysis with HPLC, mass spec, and endotoxin data
Tesamorelin is a synthetic 44-amino acid peptide analog of growth hormone-releasing hormone (GHRH) modified with a trans-3-hexenoic acid group at the N-terminus, which enhances its stability and biological activity profile.
Published clinical research has examined Tesamorelin's receptor binding characteristics on the GHRH receptor and its downstream effects on the GH-IGF-1 axis. It has been the subject of multiple Phase III clinical trials.
Manufactured under cGMP-equivalent protocols and verified to ≥99% purity via HPLC. Full COA included with every order.
Supplied as a lyophilized white powder. Soluble in sterile water and bacteriostatic water. For research and laboratory use only.
Tesamorelin is a synthetic 44-amino acid GHRH analog modified with a trans-3-hexenoic acid group. It is intended exclusively for in-vitro and laboratory research applications.
Verified at ≥99% purity via reverse-phase HPLC. Each lot includes mass spectrometry confirmation and endotoxin testing. Full COA included.
Lyophilized: -20°C long-term, stable at 2–8°C for 90 days. Reconstituted: 2–8°C, use within 28 days. Protect from light.
Yes. Every order includes a lot-specific COA with HPLC chromatography, mass spec data, peptide content, and endotoxin levels.
Orders before 2PM EST ship same day. Standard delivery is 2–4 business days within the continental US. All orders include tracking.
Still have questions about Tesamorelin or any of our research compounds?
Contact Our Research Team →
